DK407383A - Diaminopyrimidiner, fremgangsmaader til deres fremstilling, deres anvendelse og mellemprodukter anvendelige ved forbindelsernes fremstilling - Google Patents

Diaminopyrimidiner, fremgangsmaader til deres fremstilling, deres anvendelse og mellemprodukter anvendelige ved forbindelsernes fremstilling Download PDF

Info

Publication number
DK407383A
DK407383A DK407383A DK407383A DK407383A DK 407383 A DK407383 A DK 407383A DK 407383 A DK407383 A DK 407383A DK 407383 A DK407383 A DK 407383A DK 407383 A DK407383 A DK 407383A
Authority
DK
Denmark
Prior art keywords
preparation
diaminopyrimidines
procedures
compounds
intermediates used
Prior art date
Application number
DK407383A
Other languages
English (en)
Other versions
DK158310C (da
DK158310B (da
DK407383D0 (da
Inventor
Leslie M Werbel
Jocelyn H Hung
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK407383D0 publication Critical patent/DK407383D0/da
Publication of DK407383A publication Critical patent/DK407383A/da
Publication of DK158310B publication Critical patent/DK158310B/da
Application granted granted Critical
Publication of DK158310C publication Critical patent/DK158310C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK407383A 1982-09-09 1983-09-08 Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved DK158310C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41640482A 1982-09-09 1982-09-09
US41640482 1982-09-09
US52065383 1983-08-09
US06/520,653 US4532240A (en) 1982-09-09 1983-08-09 Diaminopyrimidines

Publications (4)

Publication Number Publication Date
DK407383D0 DK407383D0 (da) 1983-09-08
DK407383A true DK407383A (da) 1984-03-10
DK158310B DK158310B (da) 1990-04-30
DK158310C DK158310C (da) 1990-10-15

Family

ID=27023342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK407383A DK158310C (da) 1982-09-09 1983-09-08 Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved

Country Status (9)

Country Link
US (1) US4532240A (da)
EP (1) EP0103464B1 (da)
AU (2) AU560971B2 (da)
CA (1) CA1251447A (da)
DE (1) DE3378469D1 (da)
DK (1) DK158310C (da)
ES (2) ES8502989A1 (da)
GR (1) GR79058B (da)
IE (1) IE56148B1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
LU86695A1 (fr) * 1986-12-01 1988-07-14 Oreal Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique
HUT64323A (en) * 1992-06-09 1993-12-28 Richter Gedeon Vegyeszet Process for production new piperazinyl-bis(alkyl-amino)-pyrimidine derivatives
ATE166347T1 (de) * 1993-02-26 1998-06-15 Max Delbrueck Centrum Verfahren zur herstellung von c-nukleosiden und c-nukleosid-analoga, neue c-nukleoside und c- nukleosid-analoga, sowie ihre verwendung
DE4320570C2 (de) * 1993-02-26 2002-07-11 Max Delbrueck Centrum Verfahren zur Herstellung von C-Nukleosiden und C-Nukleosid-Analoga, neue C-Nukleoside und C-Nukleosid-Analoga sowie deren Verwendung
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
AU2076299A (en) 1998-01-30 1999-08-16 Meiji Seika Kaisha Ltd. Phenylpiperazine derivatives as integrin alphavbeta3 antagonists
US20040006042A1 (en) * 1998-08-13 2004-01-08 Berry David Allen Diaminopyrimidines and combination therapies effective for treatment of P-glycoprotein positive cancers
AU4690999A (en) * 1998-08-13 2000-03-06 Warner-Lambert Company Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers
BR0209932A (pt) * 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
GB0412072D0 (en) * 2004-05-28 2004-06-30 Syngenta Participations Ag Chemical compounds
JP6949055B2 (ja) * 2016-02-05 2021-10-13 ヴェラ ファーマシューティカルズ,エルエルシー 感染症を治療するための組成物および方法
WO2019032458A1 (en) * 2017-08-07 2019-02-14 Vyera Pharmaceuticals, LLC DHFR INHIBITORS, COMPOSITIONS AND RELATED METHODS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US416404A (en) 1889-12-03 Automatic lath-feeder for paper-carriers
BE485737A (da) * 1947-11-12
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
AT340933B (de) * 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines

Also Published As

Publication number Publication date
ES531004A0 (es) 1985-05-01
EP0103464A3 (en) 1985-07-03
DK158310C (da) 1990-10-15
AU6878787A (en) 1987-05-14
US4532240A (en) 1985-07-30
CA1251447A (en) 1989-03-21
GR79058B (da) 1984-10-02
EP0103464B1 (en) 1988-11-17
ES525490A0 (es) 1985-02-01
AU568997B2 (en) 1988-01-14
ES8502989A1 (es) 1985-02-01
DK158310B (da) 1990-04-30
DE3378469D1 (en) 1988-12-22
IE831920L (en) 1984-03-09
AU1869983A (en) 1984-03-15
EP0103464A2 (en) 1984-03-21
DK407383D0 (da) 1983-09-08
IE56148B1 (en) 1991-05-08
AU560971B2 (en) 1987-04-30
ES8504775A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
DK425583A (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf samt mellemprodukt til brug ved fremgangsmaaden
DK155583D0 (da) Hydantoiner, deres fremstilling og anvendelse
NO801469L (no) Pyrimidinforbindelser og fremgangsmaate til deres fremstilling
DK333083A (da) 2-aza-bicyclo(2.2.2)octan-3-carboxylsyrederivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og disses fremstilling
DK446982A (da) Cyanosteroider og fremgangsmaade til deres fremstilling
DK210483D0 (da) Pyrogallolderivater, deres anvendelse og fremgangsmade til fremstilling deraf
DK419283A (da) Alkoholsubstituerede amider, fremgangsmaade til fremstilling heraf samt anvendelse ved fremstilling af stoebebare polyurethanelastomerer
DK407383D0 (da) Diaminopyrimidiner, fremgangsmader til deres fremstilling, deres anvendelse og mellemprodukter anvendelige ved forbindelsernes fremstilling
DK443683A (da) Triazolforbindelser og fremgangsmaader til deres fremstilling
NO822671L (no) Farmasoeytisk virksomme forbindelser og fremgangsmaate for deres fremstilling.
DK426083A (da) Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse
NO834461L (no) Fremgangsmaate ved fremstilling av l-carnitin og utgangsmaterialer anvendt ved fremgangsmaaten
DK505080A (da) Fremgangsmaade til fremstilling af 24,24-difluor1alfa,25-dihydroxycholecalciferol og mellemprodukter til brug ved fremgangsmaaden
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK60982A (da) Oxalkylerede naphthol-novolaker,fremgangsmaade til deres fremstilling og deres anvendelse
DK290583D0 (da) Benzoylpiperazinestre og fremgangsmade til deres fremstilling
NO822796L (no) Aminoorganoaminosilaner, fremgangsmaate til deres fremstilling og deres anvendelse
NO840580L (no) Tributylfenol-etersulfonater, deres anvendelse og fremgangsmaate til fremstilling av etersulfonater
DK133587A (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
DK165336C (da) Koncentrerede stofbloedgoerende midler og fremgangsmaader til deres fremstilling
DK328280A (da) Fremgangsmaade til fremstilling af 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazon og mellemprodukter herved
DK190983D0 (da) 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmade til deres fremstilling og mellemprodukter derfor
DK514382A (da) Azolylvinyldithioacetaler, deres fremstilling og anvendelse
NO824312L (no) 4-cyano-2-azetidinoner og fremgangsmaate for deres fremstilling
DK247884D0 (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider,fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen

Legal Events

Date Code Title Description
PUP Patent expired